Search clinical trials for: telmisartan/telmisartan HCTZ (Hydrochlorothiazide)

Total 387 results

Saitama Medical University
Non-Profit Organaizaion "LINE"

Unknown

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

Hypertension

Japan
Yuhan Corporation

Completed

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

Dyslipidemia & Hypertension

Korea, Republic of
RWTH Aachen University
Bayer; Heidelberg University; CTCA

Terminated

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels (ITEM)

Arterial Hypertension | Diabetes Mellitus Type 2 IRC or NIR

Germany
Addpharma Inc.

Completed

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

Hypertension | Hypercholesterolemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

Hypertension | Hyperlipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine (CKD-345 DDI)

Essential Hypertension | Hyperlipidemia

Korea, Republic of
University of New Mexico
University of Pittsburgh; Dialysis Clinic, Inc.

Terminated

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Hypertension | Proteinuria | Type II Diabetes

United States
University of California, Los Angeles
The Campbell Foundation

Completed

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Endothelial Dysfunction

United States
Biomedis International Ltd.

Unknown

Recurrent Stroke Prevention Clinical Outcome Study (RESPECTS)

Stroke | Hypertension | Blood Pressure

Japan
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
University of British Columbia
Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health...

Withdrawn

Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

Obstructive Sleep Apnea
Bayer

Completed

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

Hypertension

Italy, Spain
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Hypertension

United States
University of California, Los Angeles
California HIV/AIDS Research Program

Completed

HIV and Fat Accumulation (MATH)

HIV Infection

United States
Boehringer Ingelheim

Completed

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Hypertension
Boehringer Ingelheim

Completed

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Hypertension
Hackensack Meridian Health

Terminated

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

GVHD

United States
Stanford University

Terminated

Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

Hypertension | Insulin Resistance | Dyslipidemia

United States
The George Institute for Global Health, China
Peking University People's Hospital

Completed

Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

Hypertension

China
AstraZeneca

Completed

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

Hypertension

Russian Federation, Latvia, Romania, Slovakia, Belgium, Malta
Novartis

Completed

A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.

Hypertension

United States, Canada, Germany, Netherlands
Oregon Health and Science University
Oregon Clinical and Translational Research Institute

Completed

A Translational Approach to Gitelman Syndrome

Gitelman Syndrome

United States
Boehringer Ingelheim

Completed

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

Hypertension
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Hypertension
Addpharma Inc.

Completed

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

Hypertension,Essential

Korea, Republic of
Boehringer Ingelheim

Completed

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Hypertension | Diabetic Nephropathies

Spain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
National Heart Foundation of Bangladesh
Johns Hopkins University; National Heart Foundation Hospital and Research Institute... and other collaborators

Completed

Occurrence of Dyskalemia With Treatment for Hypertension (OK)

Hypertension | Potassium Imbalance

Bangladesh
GlaxoSmithKline

Completed

Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions

Hypertension

South Africa
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) (TRAFIC)

HIV-1 Infection

United States, Puerto Rico
Yale University
National Institute of Mental Health (NIMH); National Institute of Neurological... and other collaborators

Completed

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection (SEARCH018)

HIV Infections | Acute HIV Infection

Thailand
Boehringer Ingelheim

Completed

MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

Hypertension
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study (TRIDENT COG)

Hypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral Hemorrhage

Australia, Netherlands
Boehringer Ingelheim

Completed

Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

Hypertension
Boehringer Ingelheim

Completed

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) (ARAMIS)

Hypertension
Vanderbilt University Medical Center

Completed

Aldosterone and the Metabolic Syndrome

Glucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus | Endocrine System Diseases

United States
HK inno.N Corporation

Recruiting

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

Hypertension
Mario Negri Institute for Pharmacological Research

Completed

Telmisartan Versus Losartan in Kidney Transplantation (COSTANT)

Renal Transplant

Italy
GlaxoSmithKline

Completed

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
Hanlim Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Aligarh Muslim University

Completed

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

Metabolic Syndrome

India
Boehringer Ingelheim

Completed

Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Hypertension
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

Hypertension

United States, Canada, Germany, Russian Federation, France
Novartis

Completed

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus (ASTRIDE)

Hypertension | Diabetes Mellitus

United States
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. (CKD-345)

Essential Hypertension | Hyperlipidemia

Korea, Republic of
The George Institute
The University of New South Wales

Recruiting

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

Hypertension | Intracerebral Haemorrhage (ICH)

United Kingdom, Australia, Singapore, Georgia, Netherlands, Nigeria, Sri Lanka, Switzerland, Brazil, Malaysia, Taiwan, Vietnam
Novartis

Completed

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Hypertension

United States

3

Subscribe